5-ASA

DRUG4 trials

Sponsors

Bausch Health Americas, Inc., Centre Hospitalier Universitaire de Saint Etienne, Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW, University Hospital, Linkoeping

Conditions

PouchitisUlcerative ColitisUlcerative Colitis (UC)

Phase 3

Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)

CompletedNCT01532648

Bausch Health Americas, Inc.Ulcerative Colitis

Start: 2012-01-27End: 2013-10-02Updated: 2019-09-06

Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).

CompletedNCT02665845

Centre Hospitalier Universitaire de Saint EtienneUlcerative Colitis

Start: 2016-06-13End: 2021-05-11Updated: 2021-08-26

Phase 4

ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA

CompletedNCT05992142

Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZWUlcerative Colitis

Start: 2023-01-17End: 2024-02-01Updated: 2024-03-21

ASAPP Study - Topical 5-ASA as Prophylaxis for Pouchitis in Ulcerative Colitis Patients After Pelvic Pouch Surgery

Not yet recruitingNCT07773948

University Hospital, LinkoepingPouchitis, Ulcerative Colitis (UC)

Start: 2027-04-01End: 2031-03-31Target: 110Updated: 2026-08-19

Related Papers

P0748 Characterisation of Remission Levels in Patients with Ulcerative Colitis Treated with 5-Aminosalicylates: Results of the CARUC-ASA Prospective Multicentre Study

Journal of Crohn s and Colitis2025-01-01